{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:37:44Z","timestamp":1760027864886},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.bbrc.2024.149963","type":"journal-article","created":{"date-parts":[[2024,4,18]],"date-time":"2024-04-18T01:56:51Z","timestamp":1713405411000},"page":"149963","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Kreotoxin A administration inhibits hyperproliferation and inflammation of human ear keloid tissue and keloid-derived fibroblasts by downregulating HIF-1\u03b1 expression"],"prefix":"10.1016","volume":"715","author":[{"given":"Hua","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingmei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhilin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2024.149963_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jccw.2016.10.001","article-title":"Novel insights on understanding of keloid scar: article review","volume":"7","author":"Mari","year":"2015","journal-title":"J. Am. College Clin. Wound Special."},{"key":"10.1016\/j.bbrc.2024.149963_bib2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/01.ASW.0000482993.64811.74","article-title":"Keloid management: a retrospective case review on a new approach using surgical excision, platelet-rich plasma, and in-office superficial photon X-ray radiation therapy","volume":"29","author":"Jones","year":"2016","journal-title":"Adv. Skin Wound Care"},{"key":"10.1016\/j.bbrc.2024.149963_bib3","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/DSS.0000000000001145","article-title":"Advancing keloid treatment: a novel multimodal approach to ear keloids","volume":"43","author":"Jones","year":"2017","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.bbrc.2024.149963_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40257-016-0175-7","article-title":"Keloids and hypertrophic scars: a spectrum of clinical challenges","volume":"17","author":"Trace","year":"2016","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.bbrc.2024.149963_bib5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/exd.12419","article-title":"Human hypertrophic and keloid scar models: principles, limitations and future challenges from a tissue engineering perspective","volume":"23","author":"van den Broek","year":"2014","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.bbrc.2024.149963_bib6","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00403-006-0651-7","article-title":"Quality of life of patients with keloid and hypertrophic scarring","volume":"297","author":"Bock","year":"2006","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.bbrc.2024.149963_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000083259","article-title":"Botulinum toxin: mechanisms of action","volume":"53","author":"Dressler","year":"2005","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.bbrc.2024.149963_bib8","first-page":"11","article-title":"The action of botulinum toxin at the neuromuscular junction","volume":"59","author":"Sellin","year":"1981","journal-title":"Med. Biol."},{"key":"10.1016\/j.bbrc.2024.149963_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tox.2015.07.003","article-title":"Botulinum neurotoxin type A: actions beyond SNAP-25?","volume":"335","author":"Matak","year":"2015","journal-title":"Toxicology"},{"key":"10.1016\/j.bbrc.2024.149963_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/jocd.12134","article-title":"Intralesional botulinum toxin type A equally effective and better tolerated than intralesional steroid in the treatment of keloids: a randomized controlled trial","volume":"14","author":"Shaarawy","year":"2015","journal-title":"J. Cosmet. Dermatol."},{"key":"10.1016\/j.bbrc.2024.149963_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093394","article-title":"New classes of mind bomb-interacting proteins identified from yeast two-hybrid screens","volume":"9","author":"Tseng","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2024.149963_bib12","article-title":"The role of factor inhibiting HIF (FIH-1) in inhibiting HIF-1 transcriptional activity in glioblastoma multiforme","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrc.2024.149963_bib13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1042\/CS20140012","article-title":"The role of the miR-31\/FIH1 pathway in TGF-\u03b2-induced liver fibrosis","volume":"129","author":"Hu","year":"2015","journal-title":"Clin. Sci."},{"key":"10.1016\/j.bbrc.2024.149963_bib14","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1096\/fj.14-252379","article-title":"Factor\u2010inhibiting HIF\u20101 (FIH\u20101) is required for human vascular endothelial cell survival","volume":"29","author":"Kiriakidis","year":"2015","journal-title":"Faseb. J."},{"key":"10.1016\/j.bbrc.2024.149963_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0003-2697(78)90342-1","article-title":"Determination of malonaldehyde precursor in tissues by thiobarbituric acid test","volume":"86","author":"Uchiyama","year":"1978","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bbrc.2024.149963_bib16","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nrm2952","article-title":"Mitochondria and cell death: outer membrane permeabilization and beyond","volume":"11","author":"Tait","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2024.149963_bib17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.molcel.2010.01.025","article-title":"The BCL-2 family reunion","volume":"37","author":"Chipuk","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbrc.2024.149963_bib18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrm2312","article-title":"Apoptosis: controlled demolition at the cellular level","volume":"9","author":"Taylor","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbrc.2024.149963_bib19","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1016\/j.jid.2020.01.036","article-title":"Hypoxia and HIF-1\u03b1 regulate collagen production in keloids","volume":"140","author":"Kang","year":"2020","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.bbrc.2024.149963_bib20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2133.2010.10048.x","article-title":"Fibroblasts from the growing margin of keloid scars produce higher levels of collagen I and III compared with intralesional and extralesional sites: clinical implications for lesional site-directed therapy","volume":"164","author":"Syed","year":"2011","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bbrc.2024.149963_bib21","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.3760\/cma.j.issn.0366-6999.20130833","article-title":"Pressure therapy upregulates matrix metalloproteinase expression and downregulates collagen expression in hypertrophic scar tissue","volume":"126","author":"Huang","year":"2013","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.bbrc.2024.149963_bib22","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41586-019-0874-3","article-title":"HIF-1\u03b1 metabolically controls collagen synthesis and modification in chondrocytes","volume":"565","author":"Stegen","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2024.149963_bib23","article-title":"Correlation between collagen type I\/III ratio and scar formation in patients undergoing immediate reconstruction with the round block technique after breast-conserving surgery","volume":"11","author":"Kim","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbrc.2024.149963_bib24","article-title":"Downregulation of microRNA-31 inhibits proliferation and induces apoptosis by targeting HIF1AN in human keloid","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24004996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24004996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T14:59:10Z","timestamp":1715266750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X24004996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":24,"alternative-id":["S0006291X24004996"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.149963","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kreotoxin A administration inhibits hyperproliferation and inflammation of human ear keloid tissue and keloid-derived fibroblasts by downregulating HIF-1\u03b1 expression","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.149963","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"149963"}}